CR20140283A - Combinación farmacéutica antineuritica y composiciones - Google Patents

Combinación farmacéutica antineuritica y composiciones

Info

Publication number
CR20140283A
CR20140283A CR20140283A CR20140283A CR20140283A CR 20140283 A CR20140283 A CR 20140283A CR 20140283 A CR20140283 A CR 20140283A CR 20140283 A CR20140283 A CR 20140283A CR 20140283 A CR20140283 A CR 20140283A
Authority
CR
Costa Rica
Prior art keywords
antineuritica
compositions
pharmaceutical combination
antiepileptics
vitamins
Prior art date
Application number
CR20140283A
Other languages
English (en)
Inventor
Arroyo Héctor Senosiain
Paniagua María Angélica Arzola
Original Assignee
Senosiain S A De C V Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48611941&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR20140283(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Senosiain S A De C V Lab filed Critical Senosiain S A De C V Lab
Publication of CR20140283A publication Critical patent/CR20140283A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La presente invención se refiere a combinaciones farmacéuticas de dos antiepilépticos, así como combinaciones de un antiepiléptico, y vitaminas del complejo B, en donde los antiepilépticos se seleccionan de pregabalina y oxcarbazepina, y las vitaminas se
CR20140283A 2011-12-16 2014-06-16 Combinación farmacéutica antineuritica y composiciones CR20140283A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MX2011014042A MX336979B (es) 2011-12-16 2011-12-16 Combinacion farmaceutica antineuritica y composiciones.
PCT/IB2012/057345 WO2013088410A1 (es) 2011-12-16 2012-12-14 Combinación farmacéutica antineurítica y composiciones

Publications (1)

Publication Number Publication Date
CR20140283A true CR20140283A (es) 2015-03-11

Family

ID=48611941

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20140283A CR20140283A (es) 2011-12-16 2014-06-16 Combinación farmacéutica antineuritica y composiciones

Country Status (14)

Country Link
US (1) US20140323428A1 (es)
BR (1) BR112014014774A2 (es)
CA (1) CA2859487C (es)
CL (1) CL2014001581A1 (es)
CO (1) CO6990712A2 (es)
CR (1) CR20140283A (es)
DO (1) DOP2014000134A (es)
ES (1) ES2525952B1 (es)
GT (1) GT201400115A (es)
MX (1) MX336979B (es)
NI (1) NI201400058A (es)
PE (1) PE20141688A1 (es)
PL (1) PL231163B1 (es)
WO (1) WO2013088410A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2826470B1 (en) * 2013-07-19 2017-09-06 Arven Ilac Sanayi ve Ticaret A.S. Pharmaceutical combinations of pregabalin
MX2014008336A (es) 2014-07-07 2016-01-07 Pptm Internat S A R L Combinacion farmacologica antihiperalgesica, antialodinica y antiinflamatoria, composiciones farmaceuticas que la contienen, y su uso para el tratamiento del dolor neuropatico.
MX2023011799A (es) 2023-10-05 2025-05-02 Laboratorios Silanes S A De C V Tableta multiactivos en el tratamiento y control de dolor severo cronico y metodo de preparacion

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070007276A (ko) * 2003-12-29 2007-01-15 제이슨 맥데빗 재발성 의학적 증상을 치료하기 위한 조성물 및 방법
ES2416723T3 (es) * 2007-10-09 2013-08-02 Merck Patent Gmbh Composiciones farmacéuticas que contienen benfotiamina y gabapentina
US8394759B2 (en) * 2008-11-21 2013-03-12 Cymbiotics, Inc. Transdermal delivery of medicaments with combinations of cetylated fatty ester penetrant complexes

Also Published As

Publication number Publication date
CA2859487A1 (en) 2013-06-20
ES2525952B1 (es) 2015-10-05
NI201400058A (es) 2014-12-22
MX336979B (es) 2016-02-09
BR112014014774A2 (pt) 2017-06-13
MX2011014042A (es) 2013-06-17
CO6990712A2 (es) 2014-07-10
ES2525952A1 (es) 2015-01-02
GT201400115A (es) 2017-07-27
CL2014001581A1 (es) 2014-09-26
US20140323428A1 (en) 2014-10-30
DOP2014000134A (es) 2014-07-31
PE20141688A1 (es) 2014-12-03
CA2859487C (en) 2016-11-15
WO2013088410A1 (es) 2013-06-20
PL231163B1 (pl) 2019-01-31
PL409542A1 (pl) 2015-07-20

Similar Documents

Publication Publication Date Title
UY34606A (es) Péptidos sintéticos de tránsito al cloroplastos derivados de brassica.
CR20140106A (es) Compuestos y composiciones como inhibidores de la quinasa c-kit
CO6940413A2 (es) Derivados de bencilamina como inhibidores de calicreina del plasma
UY34698A (es) Combinaciones farmacéuticas que comprenden un análogo de tionucleótidos
MX2019011926A (es) Metodos utiles en la sintesis de analogos de halicondrina b.
DK3181128T3 (da) Farmaceutisk nilotinib-sammensætning
UY34472A (es) Derivados modificados de 4-fenil-piridina
MX2014014166A (es) Metodos para mejorar la seguridad del transporte de la barrera hematoencefalica.
EP2862139A4 (en) PEER SUPPORTED SHOPPING
BR112013028512A2 (pt) cápsula
DK3461351T3 (da) Bleget tobakssammensætning
JO3154B1 (ar) عوامل مضادة لـ trpv4
BR112014007261A8 (pt) dispositivo de recolha de encomendas farmacêuticas
PT2854768T (pt) Composições farmacêuticas de pemetrexed
ES1094055Y (es) Prenda de ropa interior removible
CO7151512A2 (es) Inhibidores del nampt
EP2895139A4 (en) COMPOSITIONS AND METHODS FOR DENTAL TREATMENT
EP2922549A4 (en) Novel compounds
ECSP14013305A (es) Moduladores selectivos del receptor andrógeno
CR20170090A (es) Derivados de terahidroquinolina como inhibidores del bromodominio
BR112015003168A2 (pt) blindagem contracorrente de ar para uma balança
EP2872339A4 (en) SCOREBOARD
CR20140283A (es) Combinación farmacéutica antineuritica y composiciones
BR112015009179A2 (pt) composição à base de plantas
BR112014018851A2 (pt) melhoramento da estabilidade postural administrando droxidopa